Data / Form D filings / Vimy Pharmaceuticals Inc.
Vimy Pharmaceuticals Inc.: Form D filing
Vimy Pharmaceuticals Inc., a pharmaceuticals company in Toronto, Ontario, Canada, filed a Form D with the SEC in 2026. The latest, on October 13, 2026, reports $1 million sold of a $1 million offering to 7 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2 BLOOR STREET WEST SUITE 2002, Toronto, Ontario, Canada, M4W1J
- Phone
- (416) 254-4774
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Ontario, Canada
- Year incorporated
- 2024
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2159983
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 13 | New notice | $1,010,798 | $1,010,798 | 7 | Sep 28 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David John Suchon | Executive Officer, Director | Chief Executive Officer |
| Farris Smith | Executive Officer, Director | President and Chair |
| Darryl Firsten | Director | |
| Riccardo Trecroce | Director | |
| Christopher Burkett | Director |
Every Form D from the week of Oct 12 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Vimy Pharmaceuticals Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.